Tarsus Pharmaceuticals Revenue Climbs 63.9% to $194.5 Million in Q3
Photo: TokenPost
Tarsus Pharmaceuticals' third-quarter revenue was $194.5 million, up 63.9% year over year. Cash, cash equivalents and marketable securities totaled $309.6 million as of Sept. 30. John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.
Source: TokenPost
